SRTA
Strata Critical Medical, Inc.
NASDAQ: SRTA · HEALTHCARE · MEDICAL CARE FACILITIES
$5.47
-3.36% today
Updated 2026-05-12
Market cap
$462.05M
P/E ratio
—
P/S ratio
2.02x
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$3 – $6
Volume
0.8M
Strata Critical Medical, Inc. (SRTA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $31.20M | $23.43M | $50.53M | $146.12M | $225.18M | $248.69M | $197.14M |
| Revenue growth (YoY) | — | -24.9% | +115.6% | +189.2% | +54.1% | +10.4% | -20.7% |
| Cost of revenue | $26.50M | $21.11M | $40.01M | $123.84M | $183.06M | $189.77M | $156.01M |
| Gross profit | $4.70M | $2.33M | $10.52M | $22.27M | $42.12M | $58.92M | $41.13M |
| Gross margin | 15.1% | 9.9% | 20.8% | 15.2% | 18.7% | 23.7% | 20.9% |
| R&D | $751000.00 | $861000.00 | $1.68M | $5.54M | $4.63M | $3.18M | — |
| SG&A | $10.48M | $9.29M | $30.14M | $62.51M | $95.17M | $81.71M | $60.88M |
| Operating income | $-11.54M | $-10.36M | $-24.09M | $-53.53M | $-68.12M | $-33.93M | $-22.35M |
| Operating margin | -37.0% | -44.2% | -47.7% | -36.6% | -30.3% | -13.6% | -11.3% |
| EBITDA | $-11.07M | $-9.83M | $-23.50M | $-69.87M | $-61.01M | $-27.96M | $-11.88M |
| EBITDA margin | -35.5% | -42.0% | -46.5% | -47.8% | -27.1% | -11.2% | -6.0% |
| EBIT | $-11.54M | $-10.36M | $-24.09M | $-53.53M | $-68.12M | $-33.93M | $-20.07M |
| Interest expense | — | $1000.00 | — | — | — | — | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-10.84M | $-10.16M | $-40.05M | $-27.26M | $-56.08M | $-27.31M | $41.35M |
| Net income growth (YoY) | — | +6.3% | -294.2% | +31.9% | -105.7% | +51.3% | +251.4% |
| Profit margin | -34.7% | -43.4% | -79.3% | -18.7% | -24.9% | -11.0% | 21.0% |